37 research outputs found

    Comparison of Partial Pressure of Carbon Dioxide in Arterial Blood and Transcutaneous Carbon Dioxide Monitorizaiton in Patients with Obstructive Sleep Apnea and Sleep Related Hypoventilation/Hypoxemia Syndromes

    Get PDF
    Objective There is limited number of studies conducted on the use of capnography for CO2 monitorization in sleep laboratories. In this study, it was aimed to investigate the correlation between the CO2 value measured by transcutaneous carbon dioxide (tcCO2) monitorization and partial pressure of carbon dioxide (PaCO2) levels measured with arterial blood gas analysis in patients diagnosed with obstructive sleep apnea syndrome (OSAS) and Sleep-related hypoventilation/hypoxemic syndromes (SRHHS). Materials and Methods Patients with bilevel positive airway pressure (BiPAP) treatment indication who were diagnosed with OSAS and SRHHS via polysomnography (PSG), were prospectively included in the study. Four arterial blood gas analyses were conducted from all participants (pre-and post-PSG, before and after manual bi-level positive airway pressure titration) in order to find PaCO2 levels against tcCO2 monitorization. Results Totally 30 patients with sleep-related respiratory disease (SRRD), consisting of 18 patients with OSAS and COPD, and 12 patients with OSAS and obesity hypoventilation syndrome (OHS), were included in the study. A correlation was detected between average tcCO2 level and average PaCO2 level in night PSG (r=0.600; p<0.0001). Similarly, we found a correlation between average tcCO2 level and average PaCO2 level in BiPAP titration night measurements as well (r=0.812; p=0.001). Finally, a correlation was detected between the average PaCO2 value obtained from four blood gas samples measured in both nights and the average tcCO2 value taken from two capnographies (r=0.783; p<0.001). Conclusion Comparing tcCO2 and PaCO2 values, it was determined that the average CO2 values measured by capnography correlated with the average of simultaneous arterial CO2 values measured before and after BiPAP titration

    The effectiveness of smoking cessation program in a workplace with high risk

    No full text
    Introduction: Initiatives for smoking cessation (SC) at workplace have become more prominent due to both health and safety risks associated with smoking. We aimed to determine 6-month successful SC rates of a group of employees who participated in a SC program as they worked in a workplace that exhibited high risk of fire and explosion

    A case of non-Hodgkin lymphoma coexisting with both hepatitis B and tuberculosis

    No full text
    Tuberculosis may coexist with malign diseases. Because of the similar symptoms and signs, it is often difficult to diagnose one from the other during the treatment period. In one case report, a paratracheal mass was detected using thorax computed tomography in a man with chronic hepatitis B disease after a mediastinal enlargement was shown on his chest X-ray. Histopathologic examination revealed necrotizing granulomatous inflammation, supporting tuberculosis. Then standard anti-tuberculosis treatment was initiated. At the third month of therapy, the patient was admitted to the hospital with swelling in his peripheral lymph nodes. Axillary excisional biopsy was consistent with large B-cell lymphoma

    Importance of surveillance and risk factor evaluation in patients with multiple curable malignancies

    No full text
    WOS: 000355658400015PubMed ID: 2601103

    Association between hyperlactatemia and occult cardiac failure in diabetic patients on maintenance hemodialysis

    No full text
    WOS: 000340523800025PubMed ID: 24356918Lactic acidosis as a consequence of high serum lactate levels may deepen the metabolic acidosis in patients with end-stage renal failure. Besides, certain antidiabetic may also cause raised lactate levels in diabetic patients. Therefore, it is obvious that the risk of hyperlactatemia is increased by folds in diabetic patients on chronic hemodialysis program. In this study, it is aimed to evaluate the frequency and the impact of increased serum lactate levels in prevalent diabetic hemodialysis patients. A total of 100 diabetic patients who were under maintenance hemodialysis in five different dialysis centers were included in this study. All biochemical parameters, blood gas measurements, echocardiographic data and antidiabetic treatments were statistically analyzed in terms of serum lactate levels. Out of 100 patients, 12 patients had serum lactate levels over normal limits. When the patients with normal or high serum lactate levels were defined as two different groups, statistical significance was detected between serum lactate levels and serum sodium (p = 0.019), potassium (p = 0.037) and bicarbonate levels (p = 0.028). Moreover, in patients with hyperlactatemia, the ejection fraction value was found significantly low (p = 0.005). The frequency of hyperlactatemia was not rare in prevalent diabetic hemodialysis patients. We additionally found that serum lactate level measurement may particularly help to diagnose the occult cardiac failure. However, further large scale studies are required to define the clinical significance of hyperlactatemia in the end-stage renal failure patients with diabetes mellitus

    The Frequency and Significance of Radiologically Detected Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer

    No full text
    WOS: 000307375300008PubMed ID: 22572176Objective: To investigate the frequency and significance of pulmonary nodules in patients with colorectal cancer (CRC). Subjects and Methods: Medical records of 1,344 patients with CRC who underwent thoracic computerized tomography scans between January 2003 and December 2009 were reviewed. Those with any distant metastatic disease or who were already known to have pulmonary malignancies were excluded. Number, size, shape and location of the nodules were evaluated. A multivariate analysis was performed to determine the predictive factors for evidence of metastases. Results: Of the 1,344 patients, 55 (4.09%) had nodules that met the criteria of an indeterminate pulmonary nodule. The mean follow-up time was 25 +/- 17.9 months and the mean time to develop pulmonary metastasis was 15.5 +/- 6.4 months. The nodules of 17 (30.9%) patients showed progression at follow-up; 8 had metastasized. Multivariate analysis showed multiple indeterminate pulmonary nodules (p = 0.006) of parenchymal localization (p = 0.016) with an irregular border (p = 0.002), which is predictive of metastatic disease. Conclusion: Our study has shown that multiple indeterminate pulmonary nodules with an irregular border in a parenchymal location were more likely to represent metastatic disease. However, the frequency of the occurrence of indeterminate pulmonary metastases of CRC was low. Copyright (c) 2012 S. Karger AG, Base

    Does Increased Body Mass Index Effect the Gains of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients?

    No full text
    Objective: We aimed to compare the gain of pulmonary rehabilitation (PR) in obese, pre-obese, and normal-weight patients with chronic obstructive pulmonary disease (COPD) who underwent a PR program. Methods: COPD patients (n=137) underwent pulmonary and cardiac system examination and pulmonary function tests (PFTs) before PR. Chest X-rays, arterial blood gases, body mass index, quality of life (QOL) questionnaires, anxiety and depression scores, and Modified Medical Research Council dyspnea scale (MMRC) scores were evaluated in all patients. A 6-min walk test was performed to determine the exercise capacity of the patients. All patients underwent an 8-week outpatient PR program. The patients were reevaluated at the end of 8th week in terms of all parameters. Results: The study group consisted of 44 normal-weight, 52 pre-obese, and 41 obese COPD patients. Before PR, there was no significant difference in terms of 6-min walk distance (6MWD), PFT, MMRC, or QOL scores between the groups (p>0.05 for all). After PR, partial arterial oxygen pressure and arterial saturation, MMRC, and QOL scores improved significantly in all three groups (p<0.05 for all). 6MWD and walkwork significantly increased after PR in all three groups (p<0.001 for all), but the gain in 6MWD was significantly lower in obese patients compared to pre-obese and normal-weight patients (p=0.049). Conclusion: Pre-obese and obese patients benefit from PR similarly to the normal-weight patients in terms of gas exchange, dyspnea perception, and QOL. But it seems to be that exercise capacity improves less in obese COPD patients compared to pre-obese and normal- weight patients
    corecore